Simudyne vs Ultramarin (2026)
The two members of this segment whose credibility is structural rather than published, holding opposite structures and opposite poles of the autonomy axis. Simudyne's structure is method: agent based simulators validated through a published six step process against observed statistical and behavioural dynamics, a technical guide, a public sandbox anyone can inspect, and a globally systemic bank that led the funding and described deploying the technology across credit, market and operational risk in its own words. Ultramarin's structure is supervision with skin in the game: a licensed asset management subsidiary examined by the national regulator since September 2024, running over a billion euros of the company's own money on the same platform it licenses to banks and intermediaries, with European sustainability obligations named at the article level, the strongest regulatory position in this lane. The autonomy gap between them is the lane's whole range. Nothing in Simudyne's product decides or executes, because rehearsal is the point, and its residual exposure is the unvalidated passage from simulated conclusion to live threshold. Everything in Ultramarin's chain is automated through to the order reaching the market, with governance existing as client set boundaries rather than described oversight, plus an unanswered question about signal timing between its house funds and its clients. The segment's published finding still applies to both: neither publishes a result.
- Your question is systemic. Contagion, feedback, crowding and liquidity spirals emerge from simulated participants rather than being assumed, across credit, market, operational, fraud and financial crime applications.
- Your validation standard is published. A six step process ensures simulators reproduce observed dynamics, with a technical guide, a public sandbox and six doctorates behind it.
- Your reference is a systemic bank. It led the funding and described its own deployment across three risk disciplines, naming default contagion and stress testing as live uses.
- Your supplier should hold a licence. The asset management subsidiary has been supervised nationally since September 2024, with over a billion euros running on the platform and sustainability obligations named at article level.
- Your intelligence should arrive in the wrapper you can hold. Funds, managed accounts, exchange traded products, structured products or direct research interface access on more than 2,000 companies.
- Your committee wants the vendor's own money at risk. The platform is proven by running the company's supervised funds at scale, not by a benchmark claim.
This comparison is published by AI FinTech Index, an independent research platform that publishes independent ratings of AI vendors for financial services. Simudyne and Ultramarin are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI FinTech Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Simudyne | Ultramarin | |
|---|---|---|
| Primary category | Capital Markets & Research AI | Capital Markets & Research AI |
| Founded | 2016 | 2017 |
| Headquarters | London, United Kingdom | Berlin, Germany |
| Website | simudyne.com | www.ultramarin.ai |
Side by Side
| Axis | S Simudyne |
U Ultramarin |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model Risk Management and Transparency | ||
| Operational and Outcome Evidence | ||
| AI Safety and Data Stewardship | ||
| GLBA and Data Privacy Posture | ||
| Security Certifications and Trust Center | ||
| Regulatory Status and Licensure | ||
| AI Governance and Bias Disclosure | ||
| AI Liability and Recourse | ||
| Model Supply Chain Disclosure | ||
| Core Systems and Integration Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Institution and Segment Coverage |
The short version of each
Simudyne
Simudyne validates its agent based simulators through a published six step process against observed statistical and behavioural dynamics, with a technical guide, a public sandbox anyone can inspect, six doctorates on staff, and a globally systemic bank that led the funding and described deploying the technology across credit, market and operational risk in its own words. The AI FinTech Index records the position as the strongest on model risk in its lane precisely because nothing in the product decides or executes, rehearsal being the point, and records the residual exposures: the passage from simulated conclusion to live threshold, where rehearsal output tunes execution algorithms and fraud systems, carries no described validation between the two environments, and no supervisory stress testing regime is named anywhere despite the flagship use serving one. A published method is still not a performance figure, which is the segment finding the index applies to both members of this pair.
Source: AI FinTech Index, 2026
Ultramarin
Ultramarin holds the strongest regulatory position in its lane, a licensed asset management subsidiary examined by the national regulator since September 2024, running over a billion euros of the company's own money on the same platform it licenses to banks and intermediaries, with European sustainability obligations named at article level. The AI FinTech Index records supervision with skin in the game as credibility of a kind marketing cannot manufacture, and records the opposite pole it occupies on autonomy: everything in the chain is automated through to the order reaching the market, with no published checkpoint, governance existing as client set boundaries rather than described oversight, an unanswered sequencing question between the house funds and the clients consuming the same signals, and no published performance result, attestation or hosting arrangement beside the licence.
Source: AI FinTech Index, 2026
Common questions
Do Simudyne and Ultramarin compete?
No. Simudyne sells simulation for rehearsing decisions, primarily to large banks across risk disciplines, while Ultramarin runs equity investment processes end to end for banks, family offices and intermediaries, so the buyer and the job differ entirely. Graded by AI FinTech Index against the same capability axes from each vendor's own published materials, verified August 23, 2026. No vendor pays for placement.
How does each earn credibility without a track record?
Structurally, and differently. Simudyne publishes a six step validation methodology with a public sandbox, and Ultramarin operates under a national licence with over a billion euros of its own funds on the platform. The AI FinTech Index records both as answering the segment's missing track record structurally rather than with published results.
How do the autonomy positions compare?
They are the lane's poles. Nothing in Simudyne's system decides or executes, while Ultramarin automates through to execution with no published checkpoint, so the pair spans the whole axis. Graded by AI FinTech Index against the same capability axes from each vendor's own published materials, verified August 23, 2026. No vendor pays for placement.
What should a buyer press each on?
Ask Simudyne what validates simulation conclusions before they tune live execution and fraud thresholds. Ask Ultramarin where a human can intervene in the automated chain and how house fund and client signal timing is sequenced. Graded by AI FinTech Index against the same capability axes from each vendor's own published materials, verified August 23, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Capital Markets & Research AI page.
These are the two members of this segment whose answer to the published finding is structural rather than published, and the structures differ. Simudyne's answer is method: a validation process specified in six steps against observed reality, open to inspection through a sandbox, which is the strongest model risk position in the lane and still not a performance figure.
Ultramarin's answer is supervision and skin in the game: a licence held since 2024 and over a billion euros of its own money on the platform, which is the strongest regulatory position in the lane and equally not a published result.
Between them stretches the whole autonomy axis: nothing in Simudyne's platform decides or executes anything, existing so decisions can be rehearsed, while Ultramarin automates the entire chain through execution with no published checkpoint, and each pole carries its exposure, rehearsal conclusions tuning live thresholds with no described validation between the two environments at one, governance by client set boundary rather than described oversight at the other, plus the unaddressed sequencing between Ultramarin's house funds and its interface clients. Simudyne names no supervisory stress regime despite serving one; Ultramarin names its regime at article level. Neither publishes an attestation, hosting arrangement, pricing or liability position.